- Home
- LENZ vs DEA Comparison
LENZ vs DEA Comparison
Compare LENZ & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- DEA
- Stock Information
- Founded
- LENZ 2019
- DEA 2011
- Country
- LENZ United States
- DEA United States
- Employees
- LENZ N/A
- DEA N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- DEA Real Estate Investment Trusts
- Sector
- LENZ Health Care
- DEA Real Estate
- Exchange
- LENZ Nasdaq
- DEA Nasdaq
- Market Cap
- LENZ 819.1M
- DEA 912.0M
- IPO Year
- LENZ 2021
- DEA 2015
- Fundamental
- Price
- LENZ $29.16
- DEA $21.57
- Analyst Decision
- LENZ Strong Buy
- DEA Hold
- Analyst Count
- LENZ 5
- DEA 4
- Target Price
- LENZ $41.80
- DEA $27.69
- AVG Volume (30 Days)
- LENZ 180.2K
- DEA 520.2K
- Earning Date
- LENZ 05-07-2025
- DEA 07-30-2025
- Dividend Yield
- LENZ N/A
- DEA 5.79%
- EPS Growth
- LENZ N/A
- DEA N/A
- EPS
- LENZ N/A
- DEA 0.41
- Revenue
- LENZ N/A
- DEA $314,385,000.00
- Revenue This Year
- LENZ N/A
- DEA $7.23
- Revenue Next Year
- LENZ $534.98
- DEA $7.93
- P/E Ratio
- LENZ N/A
- DEA $53.17
- Revenue Growth
- LENZ N/A
- DEA 6.82
- 52 Week Low
- LENZ $14.42
- DEA $19.33
- 52 Week High
- LENZ $38.93
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- LENZ 57.21
- DEA 50.58
- Support Level
- LENZ $28.14
- DEA $20.63
- Resistance Level
- LENZ $30.09
- DEA $22.19
- Average True Range (ATR)
- LENZ 1.51
- DEA 0.51
- MACD
- LENZ 0.01
- DEA 0.18
- Stochastic Oscillator
- LENZ 76.97
- DEA 59.09
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.